Italy Neauvia Organic Hydro Deluxe 2.5ml*2syrings Hyaluronic Acid Injection Dermal Filler

• Customization: Available
• Product Name: Neauvia
• MOQ: 1 Box
• Model NO.: Neauvia
• Delivery Date: Within 7 Days
• Transport Package: Box
• Specification: 2.5ml*2syringes
• Trademark: OEM
• Origin: South Korea
• Production Capacity: 10000boxs/Years

Product Description

Name	Neauvia	Country of origin	South Korea
Form	Liquid	Package	2.5ml*2syringes

Neauvia Organic Hydro-deluxe 2 x 2.5ml pre-filled syringes

Description
NEAUVIA
18 mg/ml cross-linked Hyaluronic Acid
Temporary correction of congenital and acquired soft tissue defects of the Face by intradermal injections.
Class III medical device
The box contains 2 pre-filled syringes of 2.5ml, instructions for use, a needle and a set of labels to identify the product.

NEAUVIA Organic Hydro Deluxe is a sterile, non-pyrogenic, non-cross-linked hydrogel for injections. NEAUVIA Organic Hydro Deluxe is made from highly purified sodium hyaluronate, of non-animal origin, obtained from bacterial fermentation, non-pathogenic to Man. It contains hydroxyapatite microspheres. NEAUVIA Organic Hydro Deluxe is transparent, colourless and has a low viscosity. It comes in 1.0/2.5/5.0 ml disposable pre-filled syringes with Luer Lock tips. The box contains a syringe, instructions for use, a needle and a set of labels to identify the product.

NEAUVIA Organic Hydro Deluxe is a medical injection product designed to temporarily correct congenital and acquired facial soft tissue defects by intradermal injections. Once injected, this product degrades slowly.

Composition: NEAUVIA Organic Hydro Deluxe contains 18 mg/ml of non-cross-linked sodium hyaluronate and hydroxyapatite (0.01%), Glycine and L-Proline in pyrogen-free buffered water.

CONTRAINDICATIONS:

- Autoimmune skin diseases.
- Infections and inflammations (acne, herpes, dermatitis, etc.) in or near the treatment area.
- Varicose veins in the injection area.
- Patients undergoing treatment with anticoagulants.
- Patients undergoing radiotherapy or ultrasound therapy in the treatment area.
- Patients with a tendency to develop hypertrophic scars. Patients who are hypersensitive to Hyaluronic Acid.
- Patients suffering from untreated epilepsy.
- Pregnant women and milk feeding mothers.
- Children and adolescents under the age of 18.
- Patients with a history of severe allergies.
- Patients who have received other temporary or permanent fillers in the same treatment area.
- Do not inject into the periorbital region (eyelids, dark circles, crow's feet) and the glabellar region.
- Do not inject into blood vessels.
- Do not use excessively.
- Do not use in conjunction with laser therapy, deep chemical peels or dermabrasion.
- Do not inject into the mammary gland or internal genitalia

PRECAUTIONS FOR USE:

This product can only be administered if all the specific conditions are met, in a suitable environment. It should therefore only be used by doctors who have received specialist training in dermal filler injection techniques
 

WARNINGS:

- Do not use after the expiry date.
- Do not use if packaging is damaged, opened or improperly stored.
- Do not use if the product appears abnormal (see "Description and composition").
- Apply the product immediately after opening the pack; do not store residues.
- Do not inject the product contained in the same syringe into different patients.
- Do not use the same needle for different parts of the Body.
- Do not mix the product with other substances.
- Avoid contact with quaternary ammonium salts such as benzalkonium chloride.
- Do not add medicines to the hydrogel.
- The product is for single use only; re-use may result in loss of sterility and have serious consequences for the patient's health

REACTIONS TO TREATMENT AND ADVERSE REACTIONS:

The doctor must inform the patient of any possible adverse effects associated with the application of the product which may occur immediately or some time after the injection. Following the injection of Hyaluronic Acid some adverse reactions have been noted. These include but are not limited to:
- Inflammatory reactions such as redness, swelling, erythema, etc. which may be accompanied by itching or pain on pressure, or both;
- Ecchymosis/haematomas;
- Spotting and discoloured Skin around the injection site;
- Product intolerance reactions;
- Increased sensitivity at the injection site;
- Infection;
- Unsatisfactory filling effect of the product;
- Appearance of granuloma;
- Dislocation of the product;
- Numbness;
- Grume;
- Necrosis;
- Papules and nodules at the injection site;
- Allergic reactions to one or more of the components of the product. Inform your doctor as soon as possible of any adverse reaction (above or otherwise) lasting more than a week. The implant must be checked and treated appropriately.